UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000045484
Receipt number R000051884
Scientific Title A Study to Assess the Eye Moisturizing Effects of Enzymatic Decomposed Rooster Comb (INJUV(TM)) Oral Intake in Human
Date of disclosure of the study information 2021/09/15
Last modified on 2022/01/13 10:36:44

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

A Study to Assess the Eye Moisturizing Effects of Enzymatic Decomposed Rooster Comb (INJUV(TM)) Oral Intake in Human

Acronym

A Study to Assess the Eye Moisturizing Effects of Enzymatic Decomposed Rooster Comb (INJUV(TM)) Oral Intake in Human

Scientific Title

A Study to Assess the Eye Moisturizing Effects of Enzymatic Decomposed Rooster Comb (INJUV(TM)) Oral Intake in Human

Scientific Title:Acronym

A Study to Assess the Eye Moisturizing Effects of Enzymatic Decomposed Rooster Comb (INJUV(TM)) Oral Intake in Human

Region

Japan


Condition

Condition

N/A (healthy adults)

Classification by specialty

Adult

Classification by malignancy

Others

Genomic information

NO


Objectives

Narrative objectives1

The purpose of this study is to assess the improvement effects on eye moisturization by oral intake of enzymatic decomposed rooster comb (INJUV(TM)) in human.

Basic objectives2

Safety,Efficacy

Basic objectives -Others


Trial characteristics_1


Trial characteristics_2


Developmental phase



Assessment

Primary outcomes

DEQS,Visual Analogue Scale,BUT(Tear film break-up time),Schirmer's test

Key secondary outcomes

Visual acuity examination, Intraocular pressure examination,Refraction inspection,Anti-aging QOL common questionnaire


Base

Study type

Interventional


Study design

Basic design

Single arm

Randomization

Non-randomized

Randomization unit


Blinding

Open -no one is blinded

Control

Uncontrolled

Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms

1

Purpose of intervention

Treatment

Type of intervention

Food

Interventions/Control_1

Oral intake of the test product (4 weeks)

Interventions/Control_2


Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

20 years-old <=

Age-upper limit

60 years-old >

Gender

Male and Female

Key inclusion criteria

[1]Japanese males and females aged 20-59 years
[2]Healthy individuals without chronic diseases, including eye and skin disorders
[3]Individuals who have dry eye like symptoms in their daily lives (tired eyes, rough eyes, eye dry feeling, discomfort in eyes, tingling in eyes, red eyes, difficulty in opening eyes in the morning, crumpled eyes, etc.)
[4]Individuals who works with VDT (Visual Display Terminals) for 5 days or more a week (in total 20 hours or more a week including video games, PC and mobile phone operation time)
[5]Individuals with corrected visual acuity of 1.0 or higher who are not wearing contact lenses or who can change to eyeglasses during the study period
[6]Individuals voluntarily to join the study with written informed consent
[7]Individuals who can visit study site and receive examinations on designated days
[8]Individuals judged appropriate to join this study by principal investigators

Key exclusion criteria

[1]Individuals receiving medical drugs for treatment of chronic diseases
[2]Individuals receiving/received medical drug treatment for the past 1 month except for temporary relief medication such as headache, menstrual pain, common cold, etc.
[3]Individuals under treatment or with history of mental disorders, sleep disorders, hypertension, diabetes, lipid metabolism abnormality, or other serious disorders
[4]Individuals with history of serious diseases (hepatic, renal, cardiovascular, respiratory, hematologic, etc.)
[5]Individuals with history of gastrointestinal disorders except for appendicitis
[6]Individuals who use artificial tears (eye drops) 6 times or more a day
[7]Individuals diagnosed with presbyopia or aware of presbyopia
[8]Individuals with eye disease, entropion of the eyelids, trichiasis
[9]Individuals with a definitive diagnosis of dry eye
[10]Individuals using eye drops to treat eye diseases
[11]Individuals with refractive error and not properly corrected
[12]Individuals undergoing LASIK surgery
[13]Individuals with severe astigmatism
[14]Individuals who are thought to have eye strain due to dysregulation such as neurosis
[15]Individuals with >=30.0kg/m2 BMI
[16]Individuals with drug or food allergies
[17]Individuals who have a habit of continuing to take functional foods, health foods, and supplements for the purpose of improving eye function, or who plan to take them during the study period, now and within the past 3 months
[18]Individuals who are currently or within the last 3 months taking health foods containing enzymatic decomposed rooster combs, hyaluronic acid, collagen, proteoglycans, elastin, or their precursors during the study period or individuals planning to take new those products
[19]Individuals with alcohol intake exceeding 60g/day
[20]Individuals who may significantly change their lifestyle during the study period
[21]Individuals who work at night
etc.

Target sample size

12


Research contact person

Name of lead principal investigator

1st name Yoshikazu
Middle name
Last name Yonei

Organization

Faculty of Life and Medical Sciences,Doshisha University

Division name

Anti-Aging Medical Research Center

Zip code

6100394

Address

1-3 Tatara Miyakodani,Kyotanabe City,Kyoto

TEL

0774-65-6394

Email

yyonei@mail.doshisha.ac.jp


Public contact

Name of contact person

1st name Toshiyasu
Middle name
Last name Tamura

Organization

TES Holdings Co., Ltd.

Division name

Department of Clinical Trial

Zip code

1100015

Address

6F,Kairaku Bldg,2-7-5 Higashi-Ueno,Taitou-ku,Tokyo

TEL

03-6801-8400

Homepage URL


Email

info@tes-h.co.jp


Sponsor or person

Institute

LAIMU Corporation

Institute

Department

Personal name



Funding Source

Organization

LAIMU Corporation

Organization

Division

Category of Funding Organization

Profit organization

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization

Society of Glycative Stress Research

Address

5F-11,Musashino Bldg,2-13-10 Shinjuku,Shinjuku-ku,Tokyo

Tel

03-6709-8842

Email

rinri-glycativestress@antiaging-bank.com


Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions

うえのあさがおクリニック


Other administrative information

Date of disclosure of the study information

2021 Year 09 Month 15 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled


Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Completed

Date of protocol fixation

2021 Year 08 Month 31 Day

Date of IRB

2021 Year 09 Month 10 Day

Anticipated trial start date

2021 Year 09 Month 21 Day

Last follow-up date

2021 Year 12 Month 04 Day

Date of closure to data entry

2021 Year 12 Month 05 Day

Date trial data considered complete

2021 Year 12 Month 17 Day

Date analysis concluded

2021 Year 12 Month 20 Day


Other

Other related information



Management information

Registered date

2021 Year 09 Month 14 Day

Last modified on

2022 Year 01 Month 13 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000051884


Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name